Cargando…

IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis

BACKGROUND: Liver is the most frequent metastatic site of gastric cancer (GC), especially in patients with HER2 positive GC. Exosomal integrin αvβ5 has been shown to promote liver metastasis (LM), and the cross talk between integrins and HER2 during breast cancer metastasis has been reported. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qian, Peng, Ke, Chen, Erbao, Jiang, Huiqin, Wang, Yan, Yu, Shan, Li, Wei, Yu, Yiyi, Liu, Tianshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210205/ https://www.ncbi.nlm.nih.gov/pubmed/32395495 http://dx.doi.org/10.21037/atm.2020.03.184

Ejemplares similares

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study
por: Li, Qian, et al.
Publicado: (2016)

MON-025 Activin a Increases Human Trophoblast Invasion by Up-Regulating Integrinb1 Through ALK4
por: Zhu, Shiqin, et al.
Publicado: (2020)

Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy
por: Li, Qian, et al.
Publicado: (2022)

Mining the role of angiopoietin‐like protein family in gastric cancer and seeking potential therapeutic targets by integrative bioinformatics analysis
por: Tang, Cheng, et al.
Publicado: (2020)

A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis
por: Tang, Cheng, et al.
Publicado: (2018)

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study
por: Zhang, Lingyun, et al.
Publicado: (2022)

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition
por: Cui, Yuehong, et al.
Publicado: (2016)

Phase I study of adjuvant chemotherapy with nab‐paclitaxel and S‐1 for stage III Lauren's diffuse‐type gastric cancer after D2 resection (NORDICA study)
por: Cui, Yuehong, et al.
Publicado: (2022)

c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Yu, Shan, et al.
Publicado: (2013)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling
por: Xu, Yuan-Hua, et al.
Publicado: (2018)

Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study
por: Li, Wei, et al.
Publicado: (2019)

HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
por: Han, Sanghoon, et al.
Publicado: (2020)

FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L
por: Yu, Shan, et al.
Publicado: (2016)

Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
por: Shi, Hong-Zhi, et al.
Publicado: (2017)

miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
por: Xu, Yuejuan, et al.
Publicado: (2012)

Nomograms Involving HER2 for Predicting Lymph Node Metastasis in Early Gastric Cancer
por: Mei, Yu, et al.
Publicado: (2021)

NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
por: Yan, Hongfei, et al.
Publicado: (2019)

Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1
por: He, Xu-Jun, et al.
Publicado: (2014)

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO‐CLASSIC Study
por: Yu, Yiyi, et al.
Publicado: (2019)

Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics
por: Pan, Guoqiang, et al.
Publicado: (2020)

Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression
por: Yu, Beiqin, et al.
Publicado: (2013)

PIWI-like protein 1 upregulation promotes gastric cancer invasion and metastasis
por: Gao, Chun-li, et al.
Publicado: (2018)

Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation
por: Liu, Ruiqi, et al.
Publicado: (2018)

Hyperglycemia Promotes Liver Metastasis of Colorectal Cancer via Upregulation of Integrin αvβ6
por: Wang, Ben, et al.
Publicado: (2021)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer
por: Li, He, et al.
Publicado: (2017)

The Human Gastric Juice: A Promising Source for Gastric Cancer Biomarkers
por: Felípez, Nayra, et al.
Publicado: (2023)

Roles of Integrins in Gastrointestinal Cancer Metastasis
por: Hou, Sicong, et al.
Publicado: (2021)

The Promise of Integrins as Effective Targets for Anticancer Agents
por: Rust, William L., et al.
Publicado: (2002)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

NPTX1 Promotes Metastasis via Integrin/FAK Signaling in Gastric Cancer [Retraction]
Publicado: (2023)

AEG‐1 induces gastric cancer metastasis by upregulation of eIF4E expression
por: Wu, Shengjie, et al.
Publicado: (2017)

Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries
por: Chen, Erbao, et al.
Publicado: (2018)

MicroRNA‐17 as a promising diagnostic biomarker of gastric cancer: An investigation combining TCGA, GEO, meta‐analysis, and bioinformatics
por: Hu, GaoFeng, et al.
Publicado: (2018)

The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer
por: Dong, Xueyan, et al.
Publicado: (2013)

Gastric cancer increases transmigratory potential of peripheral blood monocytes by upregulation of β1- and β2-integrins
por: Eljaszewicz, Andrzej, et al.
Publicado: (2018)

Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells
por: DONG, ZHONGYUN, et al.
Publicado: (2014)

Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer
por: Sui, Minghua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5cm6dn8n34nejq3frbt6dhduqa